The Artificial Intelligence in Drug Discovery Industry, valued at USD 1.42 billion in 2023, is projected to grow at a remarkable Compound Annual Growth Rate (CAGR) of 29.7% from 2024 to 2031, reaching an estimated USD 11.37 billion by 2031. This exponential growth is fueled by advancements in AI technology, increasing demand for efficient drug discovery processes, and the rising incidence...

The Breathalyzers Industry was valued at USD 885.45 million in 2023 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.41% from 2024 to 2031, reaching an estimated USD 1.69 billion by 2031. This growth is driven by increasing awareness of alcohol-impaired driving risks, advancements in breathalyzer technology, and the growing use of breathalyzers in law...